What is prostate cancer?
It is a tumour that in many cases grows slowly and never causes problems for years; that is why not every prostate cancer needs immediate treatment. The key is to characterise each tumour properly: its aggressiveness, its extent and the patient's own characteristics.
Risk factors include age (it becomes more common after 50–60), family history and ethnicity.
Diagnosis
The work-up starts with examination and the PSA blood test. If levels are raised or abnormal, the study can be completed with multiparametric prostate MRI and, if indicated, a prostate biopsy, now frequently guided by MRI (image fusion).
Dr. Carrión has researched biomarkers (including liquid biopsy) that help distinguish indolent from aggressive tumours, avoiding unnecessary treatment.
Treatment options
The decision depends on the tumour's risk: active surveillance for low-risk tumours, surgery (radical prostatectomy), radiotherapy, focal therapy in selected cases, or hormone treatment and advanced options in advanced or metastatic disease.
Dr. Carrión performs radical prostatectomy with a minimally invasive approach and provides personalised advice on each option, with particular attention to preserving continence and sexual function.
Personalised follow-up
After treatment, follow-up combines PSA checks, examination and, when appropriate, imaging. The goal is to detect any recurrence early, when treatment options are most effective.